NCT05007769 Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC Status WITHDRAWN Phase PHASE2
NCT05002127 A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04992312 A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT04975308 A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04974333 Development of an Information Board and Mobile Application for the Care of Type 2 Diabetes Status UNKNOWN Phase NA
NCT04967521 SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04965493 A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04957914 A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT04956640 Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04923542 Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases Status RECRUITING Phase PHASE1/PHASE2
NCT04881760 A Study of LY3437943 in Participants Who Have Obesity or Are Overweight Status COMPLETED Phase PHASE2
NCT04881747 A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants Status COMPLETED Phase PHASE1
NCT04874636 Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain Status COMPLETED Phase PHASE2
NCT04870203 Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis Status ACTIVE_NOT_RECRUITING Phase PHASE3